Since the activation of TLR3 signaling cascades results in the subsequent release of inflammatory chemokines, cytokines, adhesion molecules, and finally type I IFN [17], sustained activation of type I IFN via TLRs activation is thought to be involved in the pathogenesis of SLE [6]. Here, TLR3 is linked to systemic lupus erythematosus.